Sarcoma  >>  semaxanib (SU5416)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
semaxanib (SU5416) / Pfizer
NCT00005931: SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

Completed
2
30
US
SU5416
SUGEN
Sarcoma, Kaposi, HIV Infections
 
 

Download Options